Cargando…

Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy

BACKGROUND: Cardiomyopathy is the leading cause of death in Duchenne muscular dystrophy (DMD). Cardiac magnetic resonance (CMR) parametric mapping sequences offer insights into disease pathophysiology. We propose a novel approach by leveraging T2 mapping in conjunction with T1 and extracellular volu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sunthankar, Sudeep D., George-Durrett, Kristen, Crum, Kimberly, Slaughter, James C., Kasten, Jennifer, Raucci, Frank J., Markham, Larry W., Soslow, Jonathan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388519/
https://www.ncbi.nlm.nih.gov/pubmed/37517994
http://dx.doi.org/10.1186/s12968-023-00951-y
_version_ 1785082136684920832
author Sunthankar, Sudeep D.
George-Durrett, Kristen
Crum, Kimberly
Slaughter, James C.
Kasten, Jennifer
Raucci, Frank J.
Markham, Larry W.
Soslow, Jonathan H.
author_facet Sunthankar, Sudeep D.
George-Durrett, Kristen
Crum, Kimberly
Slaughter, James C.
Kasten, Jennifer
Raucci, Frank J.
Markham, Larry W.
Soslow, Jonathan H.
author_sort Sunthankar, Sudeep D.
collection PubMed
description BACKGROUND: Cardiomyopathy is the leading cause of death in Duchenne muscular dystrophy (DMD). Cardiac magnetic resonance (CMR) parametric mapping sequences offer insights into disease pathophysiology. We propose a novel approach by leveraging T2 mapping in conjunction with T1 and extracellular volume (ECV) mapping to perform a virtual myocardial biopsy. While previous work has attempted to describe myocardial changes in DMD, our inclusion of T2 mapping enables comprehensive categorization of myocardial tissue characteristics of fibrosis, edema, and fat to better understand the pathological composition of the myocardium with disease progression. METHODS: DMD patients (n = 49; median: 12 years-old) underwent CMR, including T1, T2, and ECV. Categories were defined as normal, isolated high T1 (normal ECV, high T1, normal T2), fibrosis (high ECV, normal or high T1, normal T2), edema (normal or high ECV, normal or high T1, high T2), fat (normal ECV, low T1, high T2) or fibrofatty (high ECV, low T1, high T2). RESULTS: Median left ventricular ejection fraction (LVEF) was 59% with 27% having LVEF < 55%. Those with normal LVEF and no late gadolinium enhancement (37%) were younger in age (10.5 ± 2.6 vs. 15.0 ± 4.3 years-old, p < 0.001). Native T1 was elevated in at least one slice in 82% of patients. Those with high T2 at any slice (27%) were older (p = 0.005) and had lower LVEF (p = 0.005) compared with subjects with normal T2 (73%). The most common myocardial characterization was fibrosis (43%) followed by isolated high T1 (24%). Of the 13 with high T2, ten were categorized as edema, two as fibrofatty, and one as fat. CONCLUSION: CMR parametric mapping sequences offer insights into Duchenne cardiomyopathy pathophysiology, which should drive development of therapeutic interventions aimed at these targets. Myocardial fibrosis is common in DMD. Patients with elevated T2 were older and had lower LVEF. Though fat infiltration was present, the majority of subjects with elevated T2 met criteria for myocardial edema. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-023-00951-y.
format Online
Article
Text
id pubmed-10388519
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103885192023-08-01 Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy Sunthankar, Sudeep D. George-Durrett, Kristen Crum, Kimberly Slaughter, James C. Kasten, Jennifer Raucci, Frank J. Markham, Larry W. Soslow, Jonathan H. J Cardiovasc Magn Reson Research BACKGROUND: Cardiomyopathy is the leading cause of death in Duchenne muscular dystrophy (DMD). Cardiac magnetic resonance (CMR) parametric mapping sequences offer insights into disease pathophysiology. We propose a novel approach by leveraging T2 mapping in conjunction with T1 and extracellular volume (ECV) mapping to perform a virtual myocardial biopsy. While previous work has attempted to describe myocardial changes in DMD, our inclusion of T2 mapping enables comprehensive categorization of myocardial tissue characteristics of fibrosis, edema, and fat to better understand the pathological composition of the myocardium with disease progression. METHODS: DMD patients (n = 49; median: 12 years-old) underwent CMR, including T1, T2, and ECV. Categories were defined as normal, isolated high T1 (normal ECV, high T1, normal T2), fibrosis (high ECV, normal or high T1, normal T2), edema (normal or high ECV, normal or high T1, high T2), fat (normal ECV, low T1, high T2) or fibrofatty (high ECV, low T1, high T2). RESULTS: Median left ventricular ejection fraction (LVEF) was 59% with 27% having LVEF < 55%. Those with normal LVEF and no late gadolinium enhancement (37%) were younger in age (10.5 ± 2.6 vs. 15.0 ± 4.3 years-old, p < 0.001). Native T1 was elevated in at least one slice in 82% of patients. Those with high T2 at any slice (27%) were older (p = 0.005) and had lower LVEF (p = 0.005) compared with subjects with normal T2 (73%). The most common myocardial characterization was fibrosis (43%) followed by isolated high T1 (24%). Of the 13 with high T2, ten were categorized as edema, two as fibrofatty, and one as fat. CONCLUSION: CMR parametric mapping sequences offer insights into Duchenne cardiomyopathy pathophysiology, which should drive development of therapeutic interventions aimed at these targets. Myocardial fibrosis is common in DMD. Patients with elevated T2 were older and had lower LVEF. Though fat infiltration was present, the majority of subjects with elevated T2 met criteria for myocardial edema. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-023-00951-y. BioMed Central 2023-07-31 /pmc/articles/PMC10388519/ /pubmed/37517994 http://dx.doi.org/10.1186/s12968-023-00951-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sunthankar, Sudeep D.
George-Durrett, Kristen
Crum, Kimberly
Slaughter, James C.
Kasten, Jennifer
Raucci, Frank J.
Markham, Larry W.
Soslow, Jonathan H.
Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy
title Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy
title_full Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy
title_fullStr Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy
title_full_unstemmed Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy
title_short Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy
title_sort comprehensive cardiac magnetic resonance t1, t2, and extracellular volume mapping to define duchenne cardiomyopathy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388519/
https://www.ncbi.nlm.nih.gov/pubmed/37517994
http://dx.doi.org/10.1186/s12968-023-00951-y
work_keys_str_mv AT sunthankarsudeepd comprehensivecardiacmagneticresonancet1t2andextracellularvolumemappingtodefineduchennecardiomyopathy
AT georgedurrettkristen comprehensivecardiacmagneticresonancet1t2andextracellularvolumemappingtodefineduchennecardiomyopathy
AT crumkimberly comprehensivecardiacmagneticresonancet1t2andextracellularvolumemappingtodefineduchennecardiomyopathy
AT slaughterjamesc comprehensivecardiacmagneticresonancet1t2andextracellularvolumemappingtodefineduchennecardiomyopathy
AT kastenjennifer comprehensivecardiacmagneticresonancet1t2andextracellularvolumemappingtodefineduchennecardiomyopathy
AT rauccifrankj comprehensivecardiacmagneticresonancet1t2andextracellularvolumemappingtodefineduchennecardiomyopathy
AT markhamlarryw comprehensivecardiacmagneticresonancet1t2andextracellularvolumemappingtodefineduchennecardiomyopathy
AT soslowjonathanh comprehensivecardiacmagneticresonancet1t2andextracellularvolumemappingtodefineduchennecardiomyopathy